Friday, May 14, 2021

Bio-Path Holdings Inc. (BPTH) stock is rising, Here is the reason why

Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company developing DNAbilize® antisense RNAi nanoparticle technology to produce targeted nucleic acid intravenous drugs, today announced the publication of an analysis stressing upon the unrealized capacity of prexigebersen (BP1001) within the antisense oligonucleotide drug delivery space in the renowned journal, Biomedicines. BPTH stock surged adjacent to the news.


5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored



Today, in premarket trading, shares of Bio-Path Holdings Inc. (BPTH) increased 4.57% at $6.18 as of this writing. Bio-Path Holdings Inc.’s stock climbed 6.49% to finish the last trading session at $5.91.In the past 12 months, the BPTH stock has advanced 12.14%, and in the last week, the stock has moved down to -4.21%.

About Bio-Path Holdings, Inc.


A Backdoor Way To Profit From Today’s Crypto Bull Market

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .

Sponsored


The article that was titled “The Challenges and Strategies of Antisense Oligonucleotide Drug Delivery,” emphasizes the problems of an antisense oligonucleotide in the drug delivery space. Some of the challenges include lack of stability in the bloodstream, adequate delivery to specific sites, and cellular uptake. Furthermore, it is explained why prexigebersen, a liposome-incorporated antisense oligodeoxynucleotide targeted against the Grb2 mRNA, has the capability to solve the problems and revolutionize the drug delivery area.

The author of the article includes Maria Gagliardi, Ph.D., Research Scientist at Bio-Path Holdings, and Ana Tari Ashizawa, Ph.D., Senior Vice President of Research, Development, and Clinical Design at Bio-Path Holdings.

Prexigebersen has the capability to overcome problems faced by antisense oligonucleotide drug due to various reasons. Its uncharged surface has been declared non toxic in accordance to pre-clinical and clinical studies.  Furthermore, its appropriate biodistribution gives it significant therapeutic modality for cancerous tumors.

Bio-Path’s main product candidate, prexigebersen is in a Phase 2 study for blood cancers. A  drug modification of Prexigebersen, is being considered by the  Food and Drug Administration to initiate trials for tumors. After which evaluation of BP1002, targeting the Bcl-2 protein, will take place through lymphoma clinical studies.

Conclusion

Potential for prexigebersen to be used significantly in the drug delivery space has peaked investor expectation for the company. Positive data from clinical studies may further enhance BPTH stock price, considering the company’s capability to revolutionize the drug delivery space.

Latest news

What is behind the fall of Torchlight Energy Resources Inc. (NASDAQ: TRCH) stock?

Torchlight Energy Resources, Inc. (NASDAQ: TRCH), a growth oil and gas exploration company specializing in the acquisition and development of highly profitable domestic oil...

Eros STX Global Corporation (ESGC) stock is declining: Here is the reason why?

Eros STX Global Corporation (NYSE ESGC) a global multinational media company that acquires, produces, and distributes films, television shows, and digital content issued its...

Yum China Holdings Inc. (YUMC): The Most Important Numbers You Should Know

Yum China Holdings Inc. (YUMC), which operates Taco Bell Restaurants, KFC Restaurants, and Pizza Hut Restaurants in China, has published its first-quarter report for...

Why shares of Akerna Corp. (KERN) stock are up today?

Akerna (KERN), a cannabis technology company focusing to connect data points in the global cannabis supply chain and developer of the cannabis industry's first...

Related news

What is behind the fall of Torchlight Energy Resources Inc. (NASDAQ: TRCH) stock?

Torchlight Energy Resources, Inc. (NASDAQ: TRCH), a growth oil and gas exploration company specializing in the acquisition and development of highly profitable domestic oil...

Eros STX Global Corporation (ESGC) stock is declining: Here is the reason why?

Eros STX Global Corporation (NYSE ESGC) a global multinational media company that acquires, produces, and distributes films, television shows, and digital content issued its...

Yum China Holdings Inc. (YUMC): The Most Important Numbers You Should Know

Yum China Holdings Inc. (YUMC), which operates Taco Bell Restaurants, KFC Restaurants, and Pizza Hut Restaurants in China, has published its first-quarter report for...

Why shares of Akerna Corp. (KERN) stock are up today?

Akerna (KERN), a cannabis technology company focusing to connect data points in the global cannabis supply chain and developer of the cannabis industry's first...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.